Found 393 matching trials
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases PHASE1 The goal of this study is to evaluate the safety and efficacy of CD19 CAR T...
Show More Location
Henan Province Engineering Technology Research Center of Immunological Precision Medicine and Artificial Intelligence Application, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
Learn More & Join Trial
the Sequential Therapy of CD19-targeted and CD20-targeted CAR-T Cell Therapy for Diffuse Large B Cell Lymphoma(DLBCL) PHASE1 The main purpose of this study is to explore the sequential therapeutic eff...
Show More Location
Southwest Hospital of Third Millitary Medical University
Learn More & Join Trial
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases PHASE1 The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Show More Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Learn More & Join Trial
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease PHASE1 CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated...
Show More Location
Children's Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma PHASE2 This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Show More Location
Banner University Medical Center - Tucson
Learn More & Join Trial
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma PHASE1 This phase I trial studies the side effects and best dose of BCMA CART cell...
Show More Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
Learn More & Join Trial
Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy PHASE1 This is a multicenter Phase 1b study evaluating the safety, tolerability, a...
Show More Learn More & Join Trial
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease PHASE1 This is a first-in-human, single-arm, open-label study evaluating the safet...
Show More Learn More & Join Trial
Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL PHASE1 The purpose of this study is to evaluate the safety and efficiency of autol...
Show More Status
Active Not Recruiting
Location
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Learn More & Join Trial
Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma PHASE2 This phase II trial studies how well the addition of nemtabrutinib to lisoc...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial